Key Financial Data Of Group

Oncolys BioPharma Inc. - Filing #7712865

Concept 2017-01-01 to
2017-03-31
As at
2017-03-31
As at
2016-12-31
2016-01-01 to
2016-12-31
As at
2016-03-31
2016-01-01 to
2016-03-31
Key financial data of group
Business results of group
Net sales
15,380,000 JPY
178,313,000 JPY
29,560,000 JPY
Ordinary profit (loss)
-241,578,000 JPY
-864,241,000 JPY
-185,545,000 JPY
Net assets
2,712,717,000 JPY
2,617,383,000 JPY
3,295,156,000 JPY
Total assets
3,174,613,000 JPY
3,140,313,000 JPY
3,883,809,000 JPY
Basic earnings (loss) per share
-25.91
-101.18
-20.28
Diluted earnings per share
Equity-to-asset ratio
0.849 xbrli:pure
0.827 xbrli:pure
0.846 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.